Earnings in the Fore<br />By Rev Shark<br />RealMoney.com Contributor<br />7/14/2009 8:32 AM EDT <br /><br />Hope is a good breakfast, but it's a bad supper. <br />-- Francis Bacon<br /><br />On Monday the market enjoyed the "Meredith Whitney Increased Expectations" rally. Many were expecting a relatively quiet day on Monday while we awaited the onslaught of earnings news, but long-term bank bear Meredith Whitney appeared on CNBC and made very optimistic comments about upcoming earnings reports from Goldman Sachs (GS) and several others. That was all it took to ignite the buyers, who tend to be optimistic in front of big earnings reports anyway. <br /><br />The folks on CNBC were congratulating themselves for driving the market on Monday, but now this morning we will get to see if they simply led the lambs to the slaughter or helped to identify some great values that we would have missed if we didn't buy in front of the news. <br /><br />For the more thoughtful investor, the action on Monday presented a classic dilemma. Do you jump in and embrace the sudden optimism over the likelihood of good earnings, or do you avoid the risk of betting on earnings reports, particularly when expectations and the chances of disappointment are increasing? It is even more difficult when the volume isn't very heavy and technical conditions have not improved. <br /><br />Despite the surge on Monday, the major indices remain in the downtrend that began in mid-June, and we haven't managed to negate the well-observed head-and-shoulders pattern. The bulls obviously seized the advantage on Monday and may have some further momentum, especially if earnings come in OK, but the technicals, at this point, don't suggest that we embrace the market for long. <br /><br />Novellus (NVLS) , the first big technology company to report, was out last night and isn't generating much of a response so far. Dell (DELL) has some slightly negative comments that may be affecting the mood for technology just a bit, but the big report from Intel (INTC) is due tonight and will take center stage very quickly. <br /><br />Navigating the market during earnings season is always extremely tricky. The technical patterns are often rendered unreliable and the mood can shift from euphoric optimism to disappointment in the matter of minutes. A lot of folks like to bet on these earnings reports, but it really is a roll of the dice, and there is no way to have any real edge. <br /><br />Goldman Sachs should have its report soon, and I suspect it will create some very fast volatility. We can have a little more objectivity after things calm down, but for now there isn't much to do but to see where the roller coaster ride goes. <br />-----------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: ININ +14.0%, OZRK +2.5%, CSX +1.6%, JNJ +1.4%... M&A news: NOVN +22.4% (Hisamitsu to buy Noven Pharma for $16.50/share in cash; announces positive Ph. 2 top-line results)... Select financial names showing continued strength: CIT +25.9% (U.S. in talks to rescue CIT - WSJ), AIB +10.3%, AIG +4.5%, C +4.0%, FNFG +3.6%, FITB +3.4%, ING +3.2%, GNW +3.2%, LYG +2.8%, DB +2.6%, HBC +2.4%, BAC +2.2%, BCS +1.8%, ZION +1.6%... Select metals/mining names trading higher: HMY +2.7%, BHP +2.4%, BBL +2.4%, GOLD +2.4%, MT +1.7%, FCX +1.7%, RTP +1.3%.... Select oil/gas names showing strength: PBR +2.1%, PTR +1.7%, OXY +1.6%, STO +1.2%, RDS.A +1.0%... Other news: SQNM +12.2% (University of Michigan Study Shows SEQUENOM's MassARRAY technology identifies HPV infections missed by standard hybridization test), ADY +4.4% (modestly rebounding following yesterday's 15 point drop), GRA +3.6% (Cramer makes positive comments on MadMoney), UNH +2.4% (announces that its UnitedHealth Military & Veterans Services has been awarded the Department of Defense's TRICARE Managed Care Support South Region contract), AET +2.3% (wins department of Defense Tricare Contract)... Analyst comments: IMMU +8.2% (assumed with a Buy at Brean Murray; tgt $8), FCS +4.6% (initiated with Buy at Merriman), PRU +1.7% (upgraded to Overweight at JPMorgan), UL +1.4% (upgraded to Overweight at JPMorgan), BK +0.8% (upgraded to Buy at BofA/Merrill). <br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: COBZ -20.4% (also discloses it commenced an offering of ~$45 mln of its common stock), CPF -19.3% (also commences public offering of its common stock to raise gross proceeds of up to $100.0 mln), TTWO -9.8%, DELL -3.5%, MLM -3.0%, NVLS -1.1%, GS -0.6%... Other news: HNT -21.1% (not to be selected by TRICARE Management Activity for the Managed Care Support Contractor in the TRICARE North Region), HUM -8.3% (Humana's wholly-owned subsidiary, Humana Military Healthcare Services was not awarded the third generation TRICARE program contract for the South Region), AGNC -4.3% (hearing weakness attributed to pricing of secondary offering), TOT -1.4% (still checking for anything specific)... Analyst comments: MAS -3.7% (downgraded to Underweight at JPMorgan), VOD -2.0% (downgraded to Neutral at UBS), RGNC -1.7% (downgraded to Neutral from Buy at BofA/Merrill).